These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9809695)

  • 1. Insulin action and insulin resistance: diseases involving defects in insulin receptors, signal transduction, and the glucose transport effector system.
    Hunter SJ; Garvey WT
    Am J Med; 1998 Oct; 105(4):331-45. PubMed ID: 9809695
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling.
    Corbould A; Kim YB; Youngren JF; Pender C; Kahn BB; Lee A; Dunaif A
    Am J Physiol Endocrinol Metab; 2005 May; 288(5):E1047-54. PubMed ID: 15613682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Insulin resistance: from clinical diagnosis to molecular genetics. Implications in diabetes mellitus].
    Jaffiol C; Rouard M; Macari F; Lautier C; Ait el Mkadem S; Méchaly I; Brun JF; Renard E; Cros G; Bringer J; Grigorescu F
    Bull Acad Natl Med; 1999; 183(9):1761-75; discussion 1775-7. PubMed ID: 10987057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The adipose cell lineage is not intrinsically insulin resistant in polycystic ovary syndrome.
    Corbould A; Dunaif A
    Metabolism; 2007 May; 56(5):716-22. PubMed ID: 17445549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS).
    Dunaif A; Wu X; Lee A; Diamanti-Kandarakis E
    Am J Physiol Endocrinol Metab; 2001 Aug; 281(2):E392-9. PubMed ID: 11440917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance in women with polycystic ovary syndrome.
    Dunaif A
    Fertil Steril; 2006 Jul; 86 Suppl 1():S13-4. PubMed ID: 16798274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin receptors and action in clinical disorders of carbohydrate tolerance.
    Pollet RJ
    Am J Med; 1983 Nov; 75(5B):15-22. PubMed ID: 6369964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance in non-insulin dependent (type II) and insulin dependent (type I) diabetes mellitus.
    Olefsky JM; Revers RR; Prince M; Henry RR; Garvey WT; Scarlett JA; Kolterman OG
    Adv Exp Med Biol; 1985; 189():176-205. PubMed ID: 3898763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-chiro-inositol in insulin action and insulin resistance-old-fashioned biochemistry still at work.
    Larner J
    IUBMB Life; 2001 Mar; 51(3):139-48. PubMed ID: 11547915
    [No Abstract]   [Full Text] [Related]  

  • 11. [Resistance to insulin and polycystic ovary syndrome].
    Ducluzeau PH; Laville M; Vidal H; Pugeat M
    Diabetes Metab; 2001 Sep; 27(4 Pt 2):S7-12. PubMed ID: 11787441
    [No Abstract]   [Full Text] [Related]  

  • 12. [Molecular mechanisms underlying insulin resistance in skeletal muscle].
    Zierath JR; Krook A
    Lakartidningen; 2010 Nov 10-16; 107(45):2802-5. PubMed ID: 21179865
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular mechanisms of insulin receptor substrate protein-mediated modulation of insulin signalling.
    Johnston AM; Pirola L; Van Obberghen E
    FEBS Lett; 2003 Jul; 546(1):32-6. PubMed ID: 12829233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus.
    Ehrmann DA; Sturis J; Byrne MM; Karrison T; Rosenfield RL; Polonsky KS
    J Clin Invest; 1995 Jul; 96(1):520-7. PubMed ID: 7615824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow up in type A insulin resistant syndrome treated by insulin-like growth factor I.
    Ishihama H; Suzuki Y; Muramatsu K; Nagai M; Kokubo M; Shiraya H; Kawakita A; Nishimura Y; Imamura T; Kobayashi M
    Arch Dis Child; 1994 Aug; 71(2):144-6. PubMed ID: 7944536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin signalling and the regulation of glucose and lipid metabolism.
    Saltiel AR; Kahn CR
    Nature; 2001 Dec; 414(6865):799-806. PubMed ID: 11742412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unraveling the riddle of insulin resistance.
    Goldfine ID
    J Lab Clin Med; 1999 Aug; 134(2):100-2. PubMed ID: 10444021
    [No Abstract]   [Full Text] [Related]  

  • 18. Sensitivity of pyruvate dehydrogenase to insulin in activated T lymphocytes. Lack of responsiveness to insulin in patients with polycystic ovarian disease and diabetes.
    Buffington CK; Givens JR; Kitabchi AE
    Diabetes; 1990 Mar; 39(3):361-8. PubMed ID: 2407584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?
    Corbould A
    Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphism in postinsulin receptor signaling pathway is not associated with polycystic ovary syndrome.
    Jones MR; Wilson SG; Mullin BH; Mead R; Dudbridge F; Watts GF; Stuckey BG
    Fertil Steril; 2008 Dec; 90(6):2298-303. PubMed ID: 18249389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.